Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Overcoming Obstacles in AAV Viral Vector Manufacturing
Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies
James Barry, Director of Marketing, Americas, Pall Biotech
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
View All Featured ArticlesHeadline News
Abbott begins VOYAGER trial of investigational Encantor TAVI system
Kyverna completes BLA submission for miv-cel in stiff person syndrome
AbbVie invests $217m to modernise Puerto Rico biologics manufacturing campus
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Control Strategy and a Real Time Release Testing From a Development Line to Commercial Manufacturing
Presented by Tom Van Den Kerkhof Scientist at Johnson & Johnson and Sebastian Sowinski Key Account Manager at Sentronic
25th March 2020
Reducing Microbiological Risk and Using Quality Tools in the Pharmaceutical Industry
Presented by Don Singer Manager, Steriles Microbiology, for GlaxoSmithKline R&D and Jessica Rayser, Product Manager at Charles River
09th January 2019
Successful Scale Up of a High Yielding Viral Vector Suspension Platform to 500 L
Presented by John Ketz, Process Development Senior Scientist, Andelyn Biosciences, Denis Kole, Director - AcceleratorSM Processes Development Services, Pall Corporation and Benben Song, Product Manager Services, Pall Corporation
12th July 2022
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Best Practices for Achieving Virus Safety
Amsphere A3 – protein A resin: an optimized media to minimize the impact of elution buffer selection
Lifetime study for JSR Amsphere A3 – protein A resin
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















